Carin Pawlak

So geht Businessmeeting und Personalgewinnung in Perfektion!!

7

Ich freue mich, Euch im Rahmen unserer neuen LinkedIn-Serie „Life Sciences News“ regelmäßige Updates und spannende Einblicke in die Welt der #LifeSciences zu präsentieren. 📢  Wir bei K-Recruiting Life Sciences verfolgen laufend das aktuelle Geschehen in der Branche und möchten diese dynamischen Entwicklungen mit Euch teilen. ⬇️  💼 𝗠𝗮𝗻𝗸𝗶𝗻𝗱 𝗣𝗵𝗮𝗿𝗺𝗮 acquires 𝗕𝗵𝗮𝗿𝗮𝘁 𝗦𝗲𝗿𝘂𝗺𝘀 𝗮𝗻𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 for $1.6bn: BSV’s branded product portfolio spans women's health, fertility and critical care.  🌬️ Trials to watch: Four biologics concluding pivotal COPD trials: As the first biologic for COPD could soon be approved by the 𝐅𝐃𝐀, other candidates are coming to the end of pivotal studies.  👏 𝗚𝗶𝗹𝗲𝗮𝗱 receives a standing ovation for its outstanding efficacy in the HIV PrEP trial: As a leading company in HIV and AIDS research, Gilead receives a standing ovation after the full data from the Phase III PURPOSE trial was announces at AIDS 2024.  🔗 𝗗𝗿𝗲𝗻 𝗕𝗶𝗼 and 𝗡𝗼𝘃𝗮𝗿𝘁𝗶𝘀 link on bispecific antibodies for cancer: Dren Bio is eligible to receive $2.85bn in preclinical, clinical, regulatory and commercial milestone payments.  🌳𝗔𝘀𝘁𝗿𝗮𝗭𝗲𝗻𝗲𝗰𝗮 grows oncology portfolio with 𝗣𝗶𝗻𝗲𝘁𝗿𝗲𝗲`s EGFR degrader: AstraZeneca will pay $45m upfront and up to $500m in milestone-based payments for licensing Pinetree’s pre-clinical EGFR degrader.  🧬 Pipeline power: 𝗦𝗶𝗼𝗻𝗻𝗮`s 𝗔𝗯𝗯𝗩𝗶𝗲 deal could redefine CF therapeutics: The acquisition of AbbVie’s clinical compounds enhances Sionna’s ability to address these challenges and solidifies its position as a potential future player in the CF market.  👎 HHS gives thumbs down to bluebird’s fertility support programme: The US government will not give 𝗯𝗹𝘂𝗲𝗯𝗶𝗿𝗱 𝗯𝗶𝗼 the opportunity to offer fertility support to patients covered by federal insurance programmes like Medicaid.   💸𝗔𝗴𝗶𝗹𝗲𝗻𝘁 agrees to acquire 𝗕𝗜𝗢𝗩𝗘𝗖𝗧𝗥𝗔 for $925m. 🏥 𝗦𝗜𝗚𝗔 scores 𝗛𝗛𝗦 contract for smallpox vaccine Tpoxx worth $113m: The company’s Tpoxx vaccine is used to treat orthopoxvirus but is only approved for treating smallpox by the 𝐅𝐃𝐀.  💉 𝗩𝗮𝗹𝗻𝗲𝘃𝗮 and 𝗖𝗘𝗣𝗜 expand deal for chikungunya vaccine trials: The $41.3m funding from CEPI will aid in offering the vaccine in LMICs and support post-marketing trials.  💊𝗕𝗼𝗲𝗵𝗿𝗶𝗻𝗴𝗲𝗿 𝗜𝗻𝗴𝗲𝗹𝗵𝗲𝗶𝗺 offers Humira biosimilar at 92% discount: Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for $550 in a two-pack form.  ❤️ 𝗖𝗮𝗿𝗱𝘂𝗿𝗶𝗼𝗻 closes $260m in Series B to develop cardiovascular pipeline: The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart failure; and CRD-4730, a CaMKII inhibitor.  🏭 German CDMO outlays $980m on GLP-1 manufacturing expansion: As the EU anticipates GLP-1RA shortages throughout 2024, 𝗖𝗼𝗿𝗱𝗲𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 has pledged $980m to increase manufacturing capacity. Welche der heutigen News waren für Euch am relevantesten?

44

1 Kommentar

A brand's roots and core design are its North Star, giving it a unique direction in a crowded market. Without them, brands run the risk of becoming indistinguishable. It's shocking to see how many brands may be ignoring their foundation and jeopardizing their long-term viability as a result. Seeing the new Jaguar logo made me reflect on this. While modernizing is important, it raises the question: at what cost? Are we losing what made brands iconic in the first place? What are your thoughts on how brands balance evolution and heritage?

11

3 Kommentare

🆔❎ Ready - Frankly spoken how does it feel Frank S. Jorga to be just shortly kicking off ID X Summit once more? Guess everyone is excited as we are just a few hours away for one of the most important events in 2024 focussing on exchanging information and perspectives on trustworthy remote identification and the adoption of identities. CU at the #Fischauktionshalle (probably one of the most unusual hashtags I have ever used here) #IDXSummit #IDXSummit24 #IDXS24 #RemoteIdentification #VideoIdentification #DigitalSignature #ElectronicSignature

2

Excited to be part of this innovative approach to HR! Subscription-based services are a new way to deliver your people strategy and support your success in volatile markets. Let's connect and explore the possibilities! #HRInnovation #PeopleStrategy #BusinessSuccess

2

Learning from the best… wie Partizipationsprozesse zum Erfolg werden…

8

1 Kommentar

🌍 The Discussion about Purpose: Why it Matters and How to Find it 🎯 In this fast-paced world driven by results and performance, it's easy to lose sight of the bigger picture: purpose. At AIESEC in Deutschland, we believe that understanding your purpose is key to personal fulfillment and professional success. But how do you find it, and why is it so important? These are the questions we’re addressing in our latest discussions, focusing on purpose-driven leadership and impactful decision-making. This theme will also be the core of our next Youth2Business Forum, where young leaders and business professionals come together to explore how purpose can shape the future of business and society. Whether you're just starting your career or leading teams, understanding the deeper "why" behind your actions is crucial for driving long-term success and satisfaction. 💡 Let's continue the conversation: What does purpose mean to you, and how do you incorporate it into your daily life? #AIESEC #Youth2Business #PurposeDrivenLeadership #LeadershipDevelopment #PersonalGrowth #BusinessImpact

44

3 Kommentare

Read now!   #Deloitte #FinancialAdvisory #AIS #ActuarialInuranceServices #Innsurance #Versicherung #Höchstrechnungszins #Garantiezins #ZukunftGestalten

7

"Talent mobility needs to be redefined. Today, a role advertisement is more than just a full-time position for one person. It takes flexibility, understanding of projects and skills, as well as new approaches such as project-based work with freelance experts. The Future of Work calls for agile mobility and new solutions for (internal) talent development." - a great summary by Arusa Shireen Bhatti below (this quote is the translation from German). Arusa shares a portion of a panel discussion between Vidya Krishnan from Ericsson, Samantha Simmons from the LPGA, and myself, moderated by Sarah Leydon-Anand from LinkedIn from LinkedIn's #TalentConnect Show last week. Who makes up the teams working on your projects? Do they include people from other divisions and disciplines? Do they integrate external specialists filling in specific project skills needs? Your 'talent' encompasses more people now. 'Your team' can extend across and outside your organization. How are you meeting all the new skills needs on projects?

18

2 Kommentare

If you didn`t have the chance to attend this years #personamanagementkongress in Berlin 2024 and have missed our great presentation on "The Age of Adaptability" please take a look below. #humanpower #manpowergroupgermany #humanpowergroupgermany #pmk24 #pmk24berlin #coaching #assessment #careermobility

3

The proportion of women in management positions at leading German media companies is declining, according to the latest analysis by the ProQuote Medien e.V. . According to the report, the "proportion of women in power" was 38.7% in July, compared to an average of 39.5% in February. This is the first decrease in ten years. As in previous evaluations, the "taz" is the leader with 65.1% female power. For the seventh time in a row, the editorial staff of the "FAZ" brought up the rear with 23.4%. The proportion of women in management positions at "Focus" fell the most from January to July: by 5 percentage points to 25%. "Spiegel" (42.2 %), "Die Zeit" (40.1 %) and "Bild" (36.6 %) lost slightly, while the proportion of women at "Süddeutsche Zeitung" (45.0 %), "stern" (43.5 %) and "Welt" (27.6 %) increased. "Equality is not a guaranteed success," commented ProQuote board member Edith Heitkämper. Media companies and publishers must not let up in their efforts to achieve a 50:50 ratio. Equality and diversity are not a luxury, but a matter of justice, she was quoted. What do you think? 🤔 #equality #gender #women #leadership #diversity #success #media

6

6 Kommentare

Something to think about

1

This is so wholesome.

5